What are hyperreflective foci, and why do they matter in AMD? Stela Vujosevic is joined by Christine Curcio and Srinivas Sadda to explore their significance—from donor eye histology to OCT imaging. They discuss key biomarkers, clinical implications, and how HRF can help guide treatment decisions in age-related macular degeneration.
What causes central serous chorioretinopathy (CSC), and how should it be managed? In this episode, experts Camiel Boon, Sobha Sivaprasad, and Gemmy Cheung discuss the latest insights into CSC and the pachychoroid spectrum, including new imaging findings, risk factors, and treatment options like PDT, laser, and anti-VEGF.
Uveal melanoma remains a significant challenge, with genetic alterations playing a crucial role in treatment decisions. In this episode, Jens Folke Kiilgaard and Emine Kilic join Antonia Joussen to explore why metastases persist despite primary tumor treatment, the limitations of checkpoint inhibitors, and the latest on Tebentafusp and Darovasertib. We also discuss the role of adjuvant and neoadjuvant therapies and emerging T-cell therapies. Join us for an insightful discussion on the future of uveal melanoma treatment.
In this episode, Chair Alistair Laidlaw chats to Mario Romano and Stratos Gotzaridis about some of the considerations and complications surrounding the use of intraocular tamponades. They also discuss the upcoming Special Focus Meeting in Athens which will centre on vitreoretinal surgery (VR).
In this final episode of highlights from the Barcelona congress 2024, we’ll hear from Dr. Arshad Khanani about clinical trials, long term-data and the importance of personalising the treatment to the patient.
In this second episode looking at highlights from the Barcelona congress, we’ll hear about AI and sustainability in ophthalmology from Prof. Jean-francois Korobelnik of University Hospital Bordeaux.
Barcelona, We love you! Over the next few episodes, we’ll be hearing from 3 different sub-specialty experts about their favourite picks from the excellent Euretina Congress this year. This week, we hear from Ms. Rumana Hussain, Consultant Ophthalmologist specialising in Ocular Oncology and VR surgery at Liverpool University Trust Foundation Hospitals.
In this episode, Prof. Nicole Eter speaks with Dr. Yousif Subhi, this year’s Ophthalmologica lecturer about his work in meta-analyses, evidence synthesis, determination of best-practice, and clinical research.
In this episode, Professor Kyoko Ohno-Matsui discusses advancements in imaging technologies and the management of myopic maculopathy ahead of her keynote lecture at the upcoming Euretina Congress in Barcelona. Chaired by Euretina President, Professor Anat Loewenstein.
Ahead of his prestigious Gisbert Richard lecture at this year’s upcoming Euretina congress in Barcelona, David Yorston speaks to Euretina board member and former president Mr Alistair Laidlaw about his impressive career highlights and what we have learned so far from the BEAVRS Database.
In this episode, Kristina Pfau (Switzerland) and Elon Van Dijk (The Netherlands) will talk about the importance of the YOURS committee, representing young retina specialists across Europe. They’ll also discuss the opportunities that lie ahead and the challenges that are faced by early career clinicians and researchers.
In this podcast, Prof Frank Holz (Germany) discusses assessment of visual dysfunction in Intermediate AMD in the context of the Macustar trial with Dr Hannah Dunbar (UK), Principal Optometrist at Moorfields and UCL.
In this podcast, Bart Leroy (Belgium) and Mark Pennesi (USA) discuss a provocative paper in Cell that seems to draw a link between bacteria normally found in our gut and retinal diseases such as Leber congenital amaurosis (LCA) and retinitis pigmentosa (RP). This episode was an initiative of EURETINA in collaboration with ERN-EYE (European Reference Network for Rare Eye Disease).
In this episode, Zohar Habot-Wilner (Israel) and Elisabetta Miserocchi (Italy) explore the key elements of clinical examination and how to approach work up when treating patients presenting with Uveitis. The discussion is chaired by Bahram Bodhagi (France)
In this episode, something a little different from the world of basic science: an interview with Bob J Johnston of Johns Hopkins University (USA) who has been working with retinal organoids for the past decade. How are they made? What does industry think of them and will they one day become the default paradigm for retinal clinical research?
Chaired by Jonathan McCrea (Ireland).
Secretariat Address
European Society of Retina Specialists
Reinacherstrasse 131
4053 Basel
Switzerland
T +41 61 686 77 91
F +41 61 686 77 88
Email: [email protected]
Newsletter Sign up
Follow us
© EURETINA 2024 All rights reserved